Research has shown that TRIB3 physically interacts with β‐catenin and activates it in various types of tumors.[39, 40, 41] Co‐IP revealed that TRIB3 interacts with β‐catenin in colon cancer cells (Figure 4H). This evidence concerns the gene TRIB3 and malignant colon neoplasm.